Sort by
Search results
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Arachidonic Acid
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
ADP Assay for Platelet Aggregation
Investigation of congenital (e.g. Glanzmann’s thrombasthenia, Bernard-Soulier, gray platelet syndrome) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma, hepatic or renal failure). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
BIOPHEN Abnormal Control Plasma
Quality control plasma for the corresponding clotting or chromogenic assay.
BIOPHEN Normal Control Plasma
Quality control plasma for the corresponding clotting or chromogenic assays, and for non mutated FV (not resistant to APC).
BIOPHEN Plasma Calibrator
Calibration plasma for the corresponding clotting or chromogenic assays.
BIOPHEN Factor VIII:C 6
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.
BIOPHEN Factor VIII:C 2.5
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
Corn Trypsin Inhibitor (CTI)
FXIIa inhibitor.